- Home
- KRON vs CFSB Comparison
KRON vs CFSB Comparison
Compare KRON & CFSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRON
- CFSB
- Stock Information
- Founded
- KRON 2017
- CFSB 1889
- Country
- KRON United States
- CFSB United States
- Employees
- KRON 8
- CFSB N/A
- Industry
- KRON Medicinal Chemicals and Botanical Products
- CFSB Major Banks
- Sector
- KRON Health Care
- CFSB Finance
- Exchange
- KRON Nasdaq
- CFSB Nasdaq
- Market Cap
- KRON 54.1M
- CFSB 51.6M
- IPO Year
- KRON 2020
- CFSB N/A
- Fundamental
- Price
- KRON $0.88
- CFSB $13.76
- Analyst Decision
- KRON Buy
- CFSB
- Analyst Count
- KRON 3
- CFSB 0
- Target Price
- KRON $1.63
- CFSB N/A
- AVG Volume (30 Days)
- KRON 1.4M
- CFSB 10.1K
- Earning Date
- KRON 08-07-2025
- CFSB 07-29-2025
- Dividend Yield
- KRON N/A
- CFSB N/A
- EPS Growth
- KRON N/A
- CFSB N/A
- EPS
- KRON N/A
- CFSB N/A
- Revenue
- KRON $9,192,000.00
- CFSB $7,484,000.00
- Revenue This Year
- KRON N/A
- CFSB N/A
- Revenue Next Year
- KRON N/A
- CFSB N/A
- P/E Ratio
- KRON N/A
- CFSB N/A
- Revenue Growth
- KRON 21.16
- CFSB N/A
- 52 Week Low
- KRON $0.65
- CFSB $6.34
- 52 Week High
- KRON $1.60
- CFSB $13.78
- Technical
- Relative Strength Index (RSI)
- KRON 65.76
- CFSB 89.91
- Support Level
- KRON $0.87
- CFSB $13.68
- Resistance Level
- KRON $0.90
- CFSB $13.70
- Average True Range (ATR)
- KRON 0.01
- CFSB 0.01
- MACD
- KRON -0.00
- CFSB -0.19
- Stochastic Oscillator
- KRON 39.57
- CFSB 100.00
About KRON Kronos Bio Inc.
Kronos Bio Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery and development of small molecule therapeutics to address deregulated transcription, a hallmark of cancer and autoimmune diseases.
About CFSB CFSB Bancorp Inc.
CFSB Bancorp Inc provides banking services. It offers a variety of financial services to individuals and small businesses through its offices in Quincy, Holbrook, and Weymouth. Its primary deposit products are savings, checking, and term certificate accounts, and its primary lending product is residential mortgage loans.The Company's loan portfolio includes residential real estate, commercial real estate, construction, and consumer loan segments. Residential real estate loans include classes for one- to four-family, multi-family, second mortgages and home equity lines of credit.